A Silicon Valley AI shop has been OK’d by the FDA to market software that automatically flags suspected pulmonary embolisms (PEs) and immediately notifies physicians.

Researchers have demonstrated a deep learning model that can correct course for breast radiologists who otherwise may have erroneously deemed tissue dense in screening exams.

A review and update for the Centers for Medicare and Medicaid Services (CMS) Merit-based Incentive Payment System (MIPS) by in 2022 with Barbara Rubel and Claudia Murray with information they presented at this year's RBMA meeting.

The Food & Drug Administration has drafted guidelines to help U.S. healthcare better prepare for and respond to events associated with these situations.

A multidisciplinary panel convened by the ACR has developed a set of quality measures aimed at boosting rates of appropriate follow-up care for patients with noncritical but actionable incidental findings.

Iodinated contrast is most widely used in patients undergoing CT studies for, in descending order, abdominopelvic, chest, head/neck and brain indications.

Computer-aided detection boosted by AI has often proven superior to traditional CAD over the past decade, yet the “new way” has been slow to win broad adoption.

The company says the approval for ablations will allow interventional radiologists to perform these operations with nonlinear steering that facilitates high accuracy and average skin-to-target times under nine minutes.